Skip to content
DTB Podcast cover art

All Episodes

DTB Podcast — 189 episodes · page 1 of 2

#
Title
1

When doctor becomes patient: levelling up the medical hierarchy

2

When medicines cause harm: learning from the DES disaster

3

Understanding clinical significance, and the new epinephrine nasal spray

4

GLP-1 drugs, reducing sedative use, and a thank you

5

Disinformation and misinformation, AI in primary care and antidepressant tapering

6

Prevention in primary care, elinzanetant for menopause, and a farewell to David.

7

Medicines - but at what cost, direct penicillin allergy challenge, and prescribing mistakes

8

Orphan drugs, allopurinol and CVD, mavacamten for obstructive hypertrophic cardiomyopathy

9

Antibiotic susceptibility reports, deprescribing, and heart failure drugs

10

AI and DTB, drug safety, tirzepatide, and lecanemab for Alzheimer's disease

11

National asthma guidelines, bisoprolol for COPD and abaloparatide for osteoporosis

12

Identifying VTE in early pregnancy, gabapentinoids and COPD, managing ADHD

13

The polypill revisited, cytisinicline for vaping cessation and a new co-host

14

Misuse of female empowerment to sell tests and treatments, triptan safety, use of ACEI or AIIRA in CKD

15

Paying the price, liver problems with fezolinetant, systemic anticancer treatments

16

Prioritising shared decision making, remission from type 2 diabetes, gefapixant for cough

17

PILs: all harms and no benefits, Irish College of GPs end pharma funding, Ryeqo for fibroids

18

When it comes to drugs, sex matters; menopausal HT and dementia; daridorexant for sleep

19

Supporting obesity treatment, major bleeds with anticoagulants and SSRIs, equity in COPD care

20

(Un)common sense in oncology, DOACs in device-detected AF, and hypertension in the elderly

21

Medicines optimisation measures, warfarin-tramadol interaction and icosapent ethyl

22

Psychotropic medicines in children, warfarin vs DOAC in old age, and fezolinetant in menopause

23

Propranolol and its risk in overdose and managing COPD exacerbations

24

Diagnostic imaging and shielding, sinusitis, antibiotics and coloured snot, ritlecitinib

25

Medicines and global warming, donanemab for AD, and cytisine for smoking cessation

26

Drug safety alerts, valproate safety (again) and a new contraceptive POP

27

Protecting consumers, tramadol-warfarin interaction and very low calorie diets

28

ADHD medicines shortages, fluoroquinolone safety, drugs not to prescribe

29

Continuity of care, statins and myasthenia gravis, and acne

30

Rationalising blood tests, bempedoic acid and CV outcomes and semaglutide for obesity

31

BNF moving with the times; preventable deaths; plus an intro to pharmacogenetics

32

Taxing ill health, and what evidence for intravenous vitamins?

33

NICE and redacted data, spironolactone for acne, and drugs with anticholinergic activity

34

FeNO and asthma, low-dose aspirin and H pylori eradication, plus finerenone

35

July 2023: Whither evidence, COI in guidelines, isotretinoin safety, SGLT2 inhibitors and Utrogestan shortage

36

DTB 60th anniversary podcast interview - Barbara Mintzes

37

Aciclovir PEP after VZ exposure in pregnancy, falls and fractures with aspirin, an inclisiran rant

38

May 2023 - another DTB celebration (or two), OACs and NSAIDs, and siRNA-based therapeutics

39

When should you take antihypertensive medication. Prescribing for skin conditions in pregnancy

40

DTB 60th anniversary podcast interview - Joanna Girling

41

Penicillin allergy, lecanemab and Alzeimer’s disease, a new oral contraceptive and statins for all

42

Swapping to edoxaban, DOACs in renal impairment, inflammatory rheumatic diseases in pregnancy

43

DTB 60th anniversary podcast interview - John Dowden

44

Happy New Year, sad news from Australia, toxocarosis in humans and yet more on valproate safety

45

December 2022 - MHT and ’brain fog’, risks from sodium-containing paracetamol and 2022 revisited

46

DTB 60th anniversary podcast interview - Jo Congleton

47

November 2022 - FMT, methotrexate and COVID vaccine boosters, and Palforzia for peanut allergy

48

October 2022 - two freebies, advertising woes, paracetamol (again) and standing up to Pharma

49

September 2022 - healthcare costs, gout, metformin and B12, more on COI and carbetocin

50

August 2022 - COI, STOMP/STAMP, BP deprescribing, amiodarone and bempedoic acid

51

July 2022 - an e-letter, estradiol, APPGs, inclisiran and nitrofurantoin

52

June 2022 - a complaint, primary care spirometry, paracetamol and frailty, serotonin syndrome

53

May 2022 - an apology, international drug bulletins, mirtazapine and oral antivirals for covid-19

54

DTB turns 60! Plus: conflicts of interest, harms from nitrofurantoin and hypertension in pregnancy

55

March 2022 - Paracetamol and blood pressure, greener inhalers, harms from medicines and naldemedine

56

Overprescribing, overuse of short-acting beta agonists, inflammatory bowel disease in pregnancy

57

January 2022 - Molnupiravir, potentially harmful prescribing and antidepressant withdrawal reactions

58

Dec 2021 - Overprescribing, BP monitor accuracy, topical steroids, and bremelanotide and flibanserin

59

November 2021 - Drugs to avoid, penicillin allergy and a new drug for osteoporosis

60

October 2021 - Desogestrel POM to P, PCI in stable IHD, and migraine in pregnancy

61

September 2021: Aducanumab for Alzheimer’s, antibiotics, shared-decision making, and dental health

62

August 2021. Community pharmacy discharge medicines service: a step towards improved patient safety?

63

July 2021 - Chloramphenicol eye drops, boron, infants and fertility

64

June 2021 - COVID-19 vaccination in pregnancy

65

May 2021 - Time for transparency

66

April 2021 - Asthma, a disease of variability

67

March 2021 - Opioid safety: striking the right balance

68

February 2021 - Why vaccines matter

69

January 2021 - COVID-19 vaccination: we need more than the ‘mum test’

70

COVID-19 vaccines - getting the information right

71

December 2020 - Hype and hope of bedtime dosing of antihypertensives

72

November 2020 - Chronic pain (analgesia armageddon)

73

October 2020 - Making medicines safer?

74

September 2020 - Dilemmas in commissioning biological therapies

75

August 2020 - Virtual revolution

76

Low-dose aspirin for prevention of pre-eclampsia: when over the counter just isn’t

77

Deprescribing in the time of COVID-19

78

Improving consultations with children and adolescents, plus treating Covid-19 with ibuprofen

79

April 2020 - Lung volume in COPD: when less is more

80

March 2020 - Dapagliflozin for type 1 diabetes: ensuring benefits outweigh the risks

81

February 2020 - Registering our interest

82

Melatonin for jet lag

83

January 2020 - Polypharmacy and deprescribing: just ask the patient

84

December 2019 - Has the polypill finally proven its worth?

85

November 2019 - Meeting QOF hypertension targets but failing the patient

86

October 2019 -Medicines optimisation: time to review fibrates?

87

September 2019 - Social prescribing: right idea, wrong name?

88

August 2019: Time to speed up the diagnosis of pre-eclampsia

89

July 2019: It is hard work being a patient

90

June 2019: If the drugs don’t work

91

May 2019: The new GP contract - an opportunity for drugs and therapeutics

92

April 2019: DOAC dosing in renal impairment

93

March 2019: A new direction for diabetes

94

February 2019: The past, present and future of inhaled corticosteroids for COPD

95

January 2019: Challenging the supremacy of intravenous antibiotics

96

December 2018: Information on medicines for patients

97

November 2018: Travelling with medicines

98

October 2018: atrial fibrillation, opioids for chronic pain and over-the-counter sildenafil

99

Here’s your New DTB!

100

August 2018: what’s your position on giving birth?